Definitive IMRT for Stage III Thymic Carcinoma: A Brief Report and Literature Review.
BACKGROUND
Thymic carcinoma is a rare malignancy often presenting at an advanced stage. Radiation therapy and chemotherapy are often the only treatment options available to physicians.


METHODS
A 70-year-old man presented with an unresectable stage III thymic tumor and was treated with 45 Gy in 25 fractions followed by a boost of 21.6 Gy in 12 fractions. He was also treated with bortezomib for multiple myeloma unrelated to his primary malignancy.


RESULTS
The patient made a full recovery following the radiation regimen and remained disease free 4 years after the treatment.


CONCLUSIONS
Exclusive treatment with intensity-modulated radiation therapy provides a viable treatment option for patients presenting with advanced stage thymic carcinoma.
Carver College of Medicine, University of Iowa , Iowa City, IA , USA.
Sarah A
SA
Dooley
Department of Radiation Oncology, University of Iowa Hospital and Clinics , Iowa City, IA , USA.
Carryn M
CM
Anderson
chemotherapy; definitive IMRT; radiation therapy; thoracic cancer; thymic carcinoma